Amicus Therapeutics
FOLD
#3908
Rank
ยฃ2.29 B
Marketcap
ยฃ7.43
Share price
-0.50%
Change (1 day)
-2.85%
Change (1 year)

Revenue for Amicus Therapeutics (FOLD)

Revenue in 2025 (TTM): ยฃ0.45 Billion

According to Amicus Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ0.44 Billion. In 2024 the company made a revenue of ยฃ0.42 Billion an increase over the revenue in the year 2023 that were of ยฃ0.31 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amicus Therapeutics from 2008 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.45 B8%
2024 ยฃ0.42 B34.3%
2023 ยฃ0.31 B15.19%
2022 ยฃ0.27 B20.24%
2021 ยฃ0.22 B18.25%
2020 ยฃ0.19 B37.72%
2019 ยฃ0.13 B93.33%
2018 ยฃ71.88 M163.07%
2017 ยฃ27.32 M580.04%
2016 ยฃ4.01 M
2015 N/A-100%
2014 ยฃ0.78 M257.25%
2013 ยฃ0.22 M-98.07%
2012 ยฃ11.39 M-17.4%
2011 ยฃ13.79 M2208.9%
2010 ยฃ0.59 M-98.5%
2009 ยฃ39.77 M289.49%
2008 ยฃ10.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Biogen
BIIB
ยฃ7.55 B 1,581.28%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ2.32 B 416.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ0.22 B-49.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ31.79 B 6,974.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
ยฃ53.19 M-88.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
ยฃ35.43 B 7,785.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark